Main > ONCOLOGY (**) > Skin Cancer>BCC>Advanced > TREAT.: > USA. R. PD-1 Binding MAb Injection

---

USA. R. PD-1 Binding MAb Injection's subsections
(*) EU Approval Date: 2021. 06.25.
(*) USA Approval Date: 2021. 02.09.
Company
Generic Name: CemipliMAb-rwlc
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 02.16
PD: Programmed Death
RTM
RTM Web-Site

USA. R. PD-1 Binding MAb Injection's products
This section has no products